Sign in
Taking people in United StatesNo phase

Rapid Treatment of PTSD With Accelerated Non-Invasive Brain Stimulation

Key facts

Who runs it
Florida State University
Where
Tallahassee, United StatesSee the site
Trial code
Status
Recruiting
People taking part
132 people, planned
Started
6 Nov 2024
Expected to end
30 Dec 2028
Type of study
Interventional, 5 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Cool B70 AP Coil - Active (dl-PFC)
  • Cool B70 AP Coil- Sham (dl-PFC)
  • Cool D-B80 AP Coil - Active (dm-PFC)
  • Cool D-B80 AP Coil - Sham (dm-PFC)
  • Cool B70 Treatment Coil - Active Only
Record updated
20 May 2026

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 18 criteriaShow less

Other criteria

  • Inclusion:
  • Adults age 18 years to 65 years old
  • Meets DSM-5 criteria for PTSD with a PCL-5 score > 33
  • No changes in psychotropic medication (if taking psychotropic medication) and/or changes in supportive psychotherapy for 1 month prior to initial visit; and clinically appropriate to maintain stable treatment regimen for duration of trial
  • Clinically competent to give informed written consent and ability to understand study procedures and to comply with them for the entire length of the study; Exclusion:
  • Medical contraindication for neuromodulation (e.g., ferrous metal in head, seizure disorder, brain tumor, stroke, aneurysm, multiple sclerosis, etc.)
  • Active substance use disorder in last 3 months or any current substance use that puts the participant at increased risk or significant impairment
  • Dementia or other cognitive disorder making unable to engage in treatment
  • Any history or diagnosis of Schizophrenia, Schizoaffective Disorder, Delusional Disorder or other psychotic illness that precludes safe participation in trial
  • Suicidal risk that precludes safe participation defined as clinical impression that the participant is at significant risk for suicide
  • OCD cannot be the primary disorder but can have OCD symptoms
  • Inability to stop taking any medication that significantly lowers the seizure threshold (e.g., tricyclic antidepressants, clozapine, etc.)
  • Current, planned, or suspected pregnancy
  • Unstable medical conditions or any current medical condition that could preclude being able to safely participate in TMS treatment (e.g., unstable metabolic abnormality, unstable angina, etc.)
  • Severe Traumatic Brain Injury
  • We will exclude non-English speakers because of the need for rapid communication during the delivery of treatments
  • Significant ongoing litigation or claims that impact research activities, as determined by the research study team. (Research may especially be impacted when mental health or pain is being evaluated for litigation or claims, such as civil and criminal cases, disability claims and worker's compensation)
  • Prior known active TMS of dorsolateral prefrontal cortex or dorsomedial prefrontal cortex or electroconvulsive therapy (ECT) -

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

This trial is currently available in United States.

  • Florida State UniversityTallahassee, United StatesContact: Isabelle M Taylor, MATaking people

About the trial

What the trial wants to find out

This study will test the clinical efficacy of an accelerated TMS (accel-TMS) protocol that rapidly addresses PTSD symptoms with 1 week (25 sessions over 5 days) of condensed treatment.

The 5 groups in the trial

  • Arm 1: active left dl-PFC accel-TMSExisting treatment, for comparison

    Acute Phase: Eligible participants will be randomized into one of the three treatment groups: active left dl-PFC accel-TMS vs. active dm-PFC accel-TMS vs. sham dl-PFC/dm-PFC accel TMS

    Treatment: Cool B70 AP Coil - Active (dl-PFC)

  • Arm 2:active dm-PFC accel-TMSExisting treatment, for comparison

    Acute Phase: Eligible participants will be randomized into one of the three treatment groups: active left dl-PFC accel-TMS vs. active dm-PFC accel-TMS vs. sham dl-PFC/dm-PFC accel TMS

    Treatment: Cool D-B80 AP Coil - Active (dm-PFC)

  • Arm 3 - sham accel-TMS dl-PFCSham treatment, for comparison

    Acute Phase: Eligible participants will be randomized into one of the three treatment groups: active left dl-PFC accel-TMS vs. active dm-PFC accel-TMS vs. sham dl-PFC/dm-PFC accel TMS

    Treatment: Cool B70 AP Coil- Sham (dl-PFC)

  • Arm 4: sham accel -TMS dm-PFCSham treatment, for comparison

    Acute Phase: Eligible participants will be randomized into one of the three treatment groups: active left dl-PFC accel-TMS vs. active dm-PFC accel-TMS vs. sham dl-PFC/dm-PFC accel TMS

    Treatment: Cool D-B80 AP Coil - Sham (dm-PFC)

  • Arm 5Existing treatment, for comparison

    Extension phase, all participants will receive active left dl-PFC accel-TMS.

    Treatment: Cool B70 Treatment Coil - Active Only

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT06544408, who can take part
Record updated
20 May 2026